GSK notice to Akums, associate on alleged trademark infringement on its Ranitidine brand Zinetac Farhat Nasim8 Sept 2022 6:23 PM ISTNew Delhi: Locking horns over alleged trademark infringement of 'Zinetac', Glaxo Smith Kline (GSK) Pharmaceuticals has issued cease and desist notices...
WHO prequalifies GSK malaria vaccine Mosquirix Ruchika Sharma8 Sept 2022 2:03 PM ISTWorking in collaboration with PATH and other partners, GSK developed Mosquirix, the first vaccine to help protect children against the deadliest form...
Indian Pharma Market sees 12.1 percent growth in August: AIOCD-AWACS Report Farhat Nasim7 Sept 2022 5:53 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) saw significant growth of 12.1 percent in value and 4.8 percent in volume, in the month of August,...
GSK, Sanofi see EU drugs regulator decision on COVID booster in weeks Ruchika Sharma6 Sept 2022 2:00 PM ISTThe vaccine could be used as a booster for people who had received any other COVID-19 vaccine, Triomphe said.
GSK new drug application for Myelofibrosis treatment Momelotinib accepted by USFDA Ruchika Sharma19 Aug 2022 2:00 PM ISTNew Delhi: GSK plc has announced that the US Food and Drug Administration (USFDA) has accepted the New Drug Application (NDA) for momelotinib, a...
FDA, EMA found no evidence of causal association between ranitidine and cancer: GSK issues statement Ruchika Sharma13 Aug 2022 12:20 PM ISTNew Delhi: In response to recent speculative commentary regarding U.S. Zantac litigation, GSK plc has issued the following statement regarding Zantac...
Indian Pharma Market Sees 14.1 Percent Growth In July Sales: AIOCD-AWACS Report Susmita Roy7 Aug 2022 11:29 AM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) has witnessed a significant growth of 14.1% in value and 7.3% in volume in the month of July across...
GSK strikes deal to allow cheap generic versions of HIV preventive medicine Ruchika Sharma30 July 2022 12:26 PM ISTMPP offers generic manufacturers the opportunity to apply to make copycat versions of the injected drug, cabotegravir, for the 90 countries that...
GSK gets USFDA nod for Benlysta for children with active lupus nephritis Ruchika Sharma29 July 2022 11:39 AM ISTLondon: GSK plc has announced that the US Food and Drug Administration (USFDA) has approved Benlysta (belimumab) for the treatment of children aged 5...
GlaxoSmithKline Pharma net profit rises 8 percent to Rs 116 crore in Q1 Ruchika Sharma26 July 2022 9:30 AM ISTRevenue from operations rose to Rs 745 crore as against Rs 718 crore in the year-ago period, GlaxoSmithKline Pharmaceuticals said in a regulatory...
GSK spins off consumer health business Haleon Ruchika Sharma18 July 2022 3:48 PM ISTGSK emerges as New GSK, focused solely on vaccines and prescription drugs.
After bruising year, GSK approaches consumer split in better health Ruchika Sharma17 July 2022 11:00 AM ISTLondon: Things are looking up for GSK and its chief Emma Walmsley as the British drugs giant prepares to spin off its consumer health business on...
